These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Efficacy, safety and potential clinical roles of the COX-2-specific inhibitors. van der Bijl P, van der Bijl P. Int J Immunopathol Pharmacol; 2003 Oct; 16(2 Suppl):17-22. PubMed ID: 14552700 [Abstract] [Full Text] [Related]
3. [Clinical application of cyclooxygenase-2 inhibitors]. Dzielska-Olczak M, Olczak S. Pol Merkur Lekarski; 2001 Jun; 10(60):480-2. PubMed ID: 11503270 [Abstract] [Full Text] [Related]
4. Use of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 (COX-2) inhibitors: indications and complications. Pascucci RA. J Am Osteopath Assoc; 2002 Sep; 102(9):487-9. PubMed ID: 12361181 [Abstract] [Full Text] [Related]
5. [Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity]. Dammann HG. Z Gastroenterol; 1999 Jan; 37(1):45-58. PubMed ID: 10091284 [Abstract] [Full Text] [Related]
11. A regional audit of the use of COX-2 selective non-steroidal anti-inflammatory drugs (NSAIDs) in rheumatology clinics in the West Midlands, in relation to NICE guidelines. Price-Forbes AN, Callaghan R, Allen ME, Rowe IF. Rheumatology (Oxford); 2005 Jul; 44(7):921-4. PubMed ID: 15827035 [Abstract] [Full Text] [Related]
12. [New NSAIDS: COX-1, COX-2, what about them?]. Peretz A. Rev Med Brux; 1998 Sep; 19(4):A399-402. PubMed ID: 9805982 [Abstract] [Full Text] [Related]
14. Clinical experience with cyclooxygenase-2 inhibitors. Lanas A. Rheumatology (Oxford); 2002 Apr; 41 Supp 1():16-22; discussion 35-42. PubMed ID: 12173276 [Abstract] [Full Text] [Related]
15. What are the risks of long-term NSAIDs and COX-2 inhibitors? DeBisschop M. J Fam Pract; 2003 Mar; 52(3):199-200. PubMed ID: 12620173 [Abstract] [Full Text] [Related]
16. Nonsteroidal anti-Inflammatory drugs and cardiovascular risk. Howard PA, Delafontaine P. J Am Coll Cardiol; 2004 Feb 18; 43(4):519-25. PubMed ID: 14975457 [Abstract] [Full Text] [Related]
17. Cyclooxygenase-2: a therapeutic target. Turini ME, DuBois RN. Annu Rev Med; 2002 Feb 18; 53():35-57. PubMed ID: 11818462 [Abstract] [Full Text] [Related]
18. [COX-2 specific inhibitors are similar--and different]. Aly A. Lakartidningen; 2000 Sep 20; 97(38):4181-2. PubMed ID: 11068393 [No Abstract] [Full Text] [Related]